JMJiarui Mi

Jiarui Mi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jiarui Mi has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaoyin Bai

    Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China

    7 shared publications
  • Hanze Du

    Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Translation Medicine Centre, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China

    6 shared publications
  • Zhengye Liu

    Department of Plastic and Aesthetic Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, Zhejiang, China

    6 shared publications
  • Haotian Chen

    Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    4 shared publications
  • Haotian Chen

    Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China

    4 shared publications
  • Olov Andersson

    Uppsala University 1 Department of Medical Cell Biology BMC, Husargatan 3, 75123 Uppsala

    4 shared publications

Latest Publications

  • Open Access

    Sarcopenia Index Predicts the Risk of Liver Diseases: Genome-Wide Association Study and Polygenic Risk Score-Based Analyses in UK Biobank Cohort

    by Jiarui Mi, Zhengye Liu, Ziqi Wan, Hanze Du, Xiaoyin Bai, Haotian Chen

    Background/Objectives: Sarcopenia, characterized by the progressive loss of skeletal muscle mass and strength, poses significant health risks. The sarcopenia index (SI) is an essential metric for quantifying sarcopenia, yet its genetic basis and implications on liver diseases remain poorly understood. Methods: We performed a genome-wide association study (GWAS) in 389,804 European individuals from the UK Biobank to identify genetic variants related to SI. Multiple post-GWAS analyses, including colocalization, transcriptome-wide association studies (TWAS), Mendelian randomization and LD score regression were analyzed. We used polygenic risk score (PRS) of SI followed by regression models and interaction analyses to evaluate the impact of SI PRS on the risk of alcoholic and non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD), liver fibrosis, end-stage liver diseases (ESLD) and liver cancer. Results: Our analysis revealed 2476 genetic variants located near or within 406 genes associated with SI. Genetic colocalization and TWAS pinpointed 30 key variants that affect both SI and skeletal muscle gene expression. LD score regression and MR analyses both indicated inverse genetic correlations and links between SI and both NAFLD and liver fibrosis risk. Furthermore, SI PRS was associated with reduced risks of NAFLD (OR = 0.97 [95% CI 0.95–0.99], p = 0.028), liver fibrosis (OR = 0.93 [95% CI 0.90–0.96], p < 0.001), MASLD (OR = 0.98 [95% CI 0.97–0.99], p < 0.001), ESLD (OR = 0.97 [95% CI 0.94–0.99], p = 0.012), and liver cancer (OR = 0.98 [95% CI 0.96–1.00], p = 0.037), but not alcoholic liver disease (OR = 0.96 [95% CI 0.92–1.02], p = 0.120). SI PRS is also associated with the decline in fatty liver index and hepatic steatosis index in MASLD population. Restricted cubic spline analyses suggested potential linear relationships between SI PRS and liver diseases, including NAFLD, MASLD and liver fibrosis. However, gene–environment interaction analyses indicated that smoking, diabetes and metabolic status could further modify the liver disease risks in individuals with high SI PRSs. Conclusions: Our study discovered genetic variants for SI and revealed potential inverse associations of SI on the risk of NAFLD, MASLD, liver fibrosis, ESLD and liver cancer. These findings could facilitate risk stratification and support targeted therapeutic strategies for liver diseases.

  • Genome-wide investigations of the lipid accumulation product index pinpoints polygenic determinants underlying pancreatitis susceptibility

    by Chia-Fu Chien, Zhengwei Qi, Zhengye Liu, Hanze Du, Ziqi Wan, Haotian Chen, Xiaoyin Bai, Jiarui Mi

    The lipid accumulation product index (LAP) is a robust marker of lipid burden. However, its genetic architecture and causal relevance to pancreatitis remain poorly characterized. We performed a genome-wide association study (GWAS) of LAP in 388,213 European from UK Biobank, followed by colocalization, transcriptome-wide association studies (TWAS), LD score regression and Mendelian randomization for causal relationships. Polygenic risk scores (PRS) were constructed and tested against chronic pancreatitis (CP), hypertriglyceridemic acute pancreatitis (HTG-AP), and acute pancreatitis (AP) using regression models. Gene-environment interactions were evaluated for dietary and lifestyle factors. The GWAS identified 235 independent loci associated with LAP; 18 and 26 genes showed significant colocalization with hepatic and visceral-adipose eQTLs, respectively. TWAS revealed 292 (PrediXcan) and 417 (JTI) genes in visceral fat, and 164 (PrediXcan) and 281 (JTI) in liver, whose expression associated with LAP. Positive genetic correlations were observed between LAP and CP (rg = 0.252) and AP (rg = 0.219). Mendelian randomization supported a causal effect of LAP on CP (β = 6.86 × 10-3, P = 0.030) and AP (β = 1.68 × 10-3, P = 0.045). Each 1-SD increase in LAP-PRS conferred higher risk of HTG-AP (OR = 1.11, 95% CI 1.02-1.20) and CP (OR = 1.07, 95% CI 1.00-1.14), but not AP. Furthermore, a healthier dietary pattern can attenuate the HTG-AP risk genetically driven by LAP PRS. This study delineates the polygenic basis of LAP and establishes its causal role in CP and HTG-AP susceptibility, offering a genetically informed indicator for risk assessment of pancreatitis.

  • Open Access

    Genome-Wide Dissection of the Neutrophil-to-Lymphocyte Ratio Uncovers Polygenic Determinants Linked to Inflammatory Gastrointestinal Disorder Susceptibility

    by Da Miao, Yao Ge, Zhengye Liu, Ziqi Wan, Haotian Chen, Xiaoyin Bai, Jiarui Mi

    Background: The neutrophil-to-lymphocyte ratio (NLR) is a simple biomarker that reflects the balance between innate immune response and adaptive immunity. Currently, the genetic basis and clinical implications of NLR in relation to inflammatory gastrointestinal diseases have not been extensively explored. Methods: We carried out a genome-wide association study (GWAS) on European individuals from the UK Biobank to detect genetic variants related to NLR, followed by post-GWAS analyses including colocalization analysis, transcriptome-wide association studies (TWAS), and LD score regression. Logistic regression, Cox regression, and gene–environment interaction analysis were used to evaluate the impact of NLR polygenic risk scores (PRS) on inflammatory gastrointestinal disease risks. Results: GWAS of 395,442 Europeans identified 306 genomic regions (731 lead SNPs) associated with NLR, mapping to 1542 genes enriched for immune pathways. Colocalization revealed shared genetic signals with TWAS prioritization of 59, 19, 14, 22 and 28 genes in the whole blood, spleen, terminal ileum, transverse colon and sigmoid colon, respectively. LD-score regression showed significant positive genetic correlations with CD (rg = 0.132), coeliac disease (rg = 0.124), peptic ulcer (rg = 0.138) and duodenal ulcer (rg = 0.220). One-SD increase in NLR PRS predicted higher risk of IBD (OR = 1.05, 95% CI 1.03–1.08), Crohn’s disease (OR = 1.06, 1.02–1.10), ulcerative colitis (OR = 1.05, 1.02–1.08) and coeliac disease (OR = 1.07, 1.03–1.11). Restricted cubic splines demonstrated non-linear relationships of NLR PRS for IBD, CD and UC. Gene environment analyses showed smoking and diabetes amplified the risks, while cardioprotective diet, oily fish intake and polyunsaturated fatty acid level attenuated NLR PRS-associated risk in IBD (mainly CD). Conclusions: Our study delineates the polygenic basis of NLR and establishes its genetic correlation with inflammatory gastrointestinal diseases, offering a genetically informed indicator for disease risk stratification with potential utility in population-level prevention strategies.


  • Open Access

    Genome-wide association and integrative analyses of relative handgrip strength identify polygenic determinants of gastrointestinal disorder susceptibility

    by Pan Jiang, Yanfei Fang, Zhengye Liu, Hanze Du, Xiaoyin Bai, Haotian Chen, Jiarui Mi

    Background: Hand grip strength is a crucial indicator of muscle strength and quality. Yet, there remain significant knowledge gaps in our understanding of the genetic factors that influence hand grip strength and its impact on digestive disorders. Methods: This study employed data from the UK Biobank, comprising 405,394 individuals of European ancestry, who underwent assessments of both left- and right- hand grip strength at baseline. We calculated the relative hand grip strength (RHGS), defined as the average hand grip strength adjusted for body mass index (BMI). Subsequently, we performed genome-wide association study (GWAS) to identify RHGS-linked variants and genes. We evaluated RHGS’s impact on digestive disorders using linkage disequilibrium score regression (LDSC), Mendelian randomization (MR), Polygenic risk score (PRS), regression models, and interaction analyses. Results: GWAS of 405,394 Europeans identified 1,111 independent SNPs across 226 autosomal loci and 407 genes associated with RHGS. TWAS with skeletal-muscle eQTLs prioritized genes, including L3MBTL3 , CEP192 and NUCKS1 , highly expressed in type I/II myocytes and mesenchymal cells. LDSC revealed significant negative genetic correlations between RHGS and abdominal hernia (rg = -0.121, p = 5.00 × 10⁻⁴), diaphragmatic hernia (rg = -0.155, p = 6.33 × 10⁻⁶) and diverticular intestine (rg = -0.141, p = 3.85 × 10⁻¹⁰). MR indicated that one-unit higher genetically predicted RHGS reduced odds of diaphragmatic hernia (OR = 0.45, 95% CI 0.25–0.82), diverticular intestine (OR = 0.42, 0.26–0.66), NAFLD (OR = 0.49, 0.29–0.83) and peptic ulcer (OR = 0.54, 0.31–0.97). Each standard-deviation increase in RHGS PRS was associated with lower risks of abdominal hernia (OR = 0.98), diaphragmatic hernia (OR = 0.96) and diverticular intestine (OR = 0.98) after full adjustment. Gene-environment analyses showed diabetes, hyperlipidemia and smoking attenuated the protective effects from elevated RHGS, whereas cardioprotective diet and higher fiber intake showed synergistic protection on abdominal hernia, diaphragmatic hernia and diverticular intestine. Conclusion: We identified multiple RHGS-associated loci enriched in skeletal muscle. Genetically high RHGS inversely correlated with risks of abdominal hernia, diaphragmatic hernia and diverticular intestine. RHGS polygenic risk score enables risk stratification, and its effects are modulated by diet and common comorbidities. Graphical The schematics of the study pipeline in the investigation of RHGS GWAS and the follow-up post-GWAS analyses for clinical relevance. RHGS: relative hand grip strength; GWAS: genome-wide association study.


  • Investigation of the impact of gynoid fat on steatotic and advanced liver diseases–Genomic and clinical perspectives from a large-scale population cohort

    by Zhengye Liu, Haotian Chen, Hanze Du, Guang Lin, Tian Tu, Ziqi Wan, Nan Zhao, Guanqiao Li, Bowen Tang, Huilin Wu, et al.

  • Open Access

    Genetic insights of waist-to-height ratio on the risk of steatotic and advanced liver diseases: genome-wide association study and polygenic risk score-based analyses

    by Haotian Chen, Zhengye Liu, Hanze Du, Ziqi Wan, Xiaoyin Bai, Jiarui Mi

    The waist-to-height ratio (WHtR) is a simple and effective indicator to measure central obesity. However, the genetic basis and clinical implications of WHtR in relation to steatotic and advanced liver diseases remain largely unexplored. We performed a genome-wide association study (GWAS) in European individuals from the UK Biobank to identify genetic variants associated with WHtR, followed by extensive post-GWAS assessments, including colocalization analysis, transcriptome-wide association studies (TWAS), and LD score regression. Logistic and Cox regression, and interaction analysis, were employed to evaluate the impact of WHtR PRS on alcoholic and non-alcoholic fatty liver disease (AFLD and NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD), liver fibrosis, end-stage liver disease (ESLD), and liver cancer. Our GWAS identified 2,280 significant single nucleotide polymorphisms (SNPs) that were independently associated with WHtR. Colocalization analyses revealed that 55 SNPs influenced both WHtR and gene expression (including VEGFB, EZH1, CCND2 and etc.) in the visceral fat tissue. TWAS confirmed the involvement of these SNPs in visceral fat gene regulation. LD score regression analysis demonstrated that WHtR had significant positive genetic correlations with AFLD (rg = 0.123, p = 4.29 × 10⁻²), NAFLD (rg = 0.178, p = 1.78 × 10⁻⁷), and liver fibrosis (rg = 0.171, p = 2.57 × 10⁻²), yet no significant association was found with hepatocellular carcinoma (rg = 0.015, p = 0.872). Furthermore, the WHtR PRS was associated with increased risk of AFLD (OR = 1.09 [95% CI 1.03–1.13], p = 0.002), NAFLD (OR = 1.10 [95% CI 1.07–1.12], p < 0.001), MASLD (OR = 1.13 [95% CI 1.12–1.14], p < 0.001) and liver fibrosis (OR = 1.11 [95% CI 1.08–1.14], p < 0.001), although there was no statistical significance in relation to ESLD (p = 0.104) and hepatocellular carcinoma (p = 0.108). These findings were further corroborated by Cox regression analysis using WHtR PRS as well as logistic and Cox regression analysis using WHtR measures. The restricted cubic spline regression suggested potential linear relationships of WHtR PRS on the risks of NAFLD, MASLD and liver fibrosis. Notably, Gene-environment interaction analysis indicated that metabolic status, diabetes, and healthy dietary patterns could modulate the genetic liability to a high WHtR to the risk of NAFLD, MASLD, and liver fibrosis. The study identified WHtR-related genetic variants and their roles in gene regulation in visceral adipose tissue. Individuals predisposed to high WHtR constituted a high-risk group in developing alcoholic liver disease, NAFLD, MASLD and liver fibrosis. Our study highlights the value of WHtR for the risk assessment and personalized disease surveillance in steatotic liver diseases. The online version contains supplementary material available at 10.1186/s40246-025-00832-8. The online version contains supplementary material available at 10.1186/s40246-025-00832-8.


  • Open Access

    Integrative genome-wide analysis unveils the genetic landscape of gallstone disease and highlights novel loci with therapeutic potential

    by Haotian Chen, Zhengye Liu, Hanze Du, Mixue Zheng, Ziqi Wan, Nan Zhao, Guanqiao Li, Xiaoyin Bai, Dong Wu, Jiarui Mi

    Objective: Gallstone disease (GD) is a common gastrointestinal disorder with a significant genetic component. Despite known risk factors, the genetic basis of GD remains incompletely understood. We aimed to identify novel genetic loci associated with GD, explore their clinical implications and investigate their therapeutic potential. Methods: We conducted a genome-wide association study from the UK Biobank followed by a meta-analysis, integrating summary statistics from the FinnGen R11, with further replication from Biobank Japan. Using systematic bioinformatic approaches, we performed gene prioritisation, colocalisation analysis, transcriptome-wide association study, Mendelian randomisations, cross-trait genetic correlations, phenome-wide association study, clinical investigations and gene-environment interactions by leveraging data from the FinnGen, Genotype-Tissue Expression project and Liver Cell Atlas single-cell transcriptomics data set. Results: Our study highlighted novel susceptibility loci near candidate genes (ie, UGT1A4 , FADS1/3 ) associated with GD, expanding the known genetic landscape. Functional annotation and colocalisation analysis implicated that the independent variants are involved in various hepatocyte functions, including bile secretion, cellular glucuronidation and cholesterol gallstone pathway. Mendelian randomisation established causal relationships between the level of unsaturated fatty acids and GD risk. We also demonstrated the implications of indirect bilirubin level in GD risk stratification and the protective effect of oily fish intake in genetically susceptible individuals. Conclusions: This study provides new insights into the genetic basis of GD and highlights the role of hepatocytes in GD pathogenesis. These findings have implications for the personalised prevention strategies and new therapeutic interventions in individuals predisposed to GD.

  • Genome-wide association study identifies FUT2 rs601338 polymorphism linking intra-pancreatic fat deposition to chronic pancreatitis

    by Haotian Chen, Xiaoyin Bai, Zhengye Liu, Hanze Du, Xiaoli Chen, Dong Wu, Jiarui Mi


  • Open Access

    Cholangiocytes contribute to hepatocyte regeneration after partial liver injury during growth spurt in zebrafish

    by Sema Elif Eski, Jiarui Mi, Macarena Pozo-Morales, Gabriel Garnik Hovhannisyan, Camille Perazzolo, Rita Manco, Imane Ez-Zammoury, Dev Barbhaya, Anne Lefort, Frédérick Libert, et al.

    The liver’s regenerative ability depends on injury extent. Minor injuries are repaired by hepatocyte self-duplication, while severe damage triggers cholangiocyte involvement in hepatocyte recovery. This paradigm is well-documented for adult animals but is less explored during rapid growth. We design two partial liver injury models in zebrafish, which were investigated during growth spurts: 1) partial ablation, killing half the hepatocytes; and 2) partial hepatectomy, removing half a liver lobe. In both injuries, de novo hepatocytes emerged alongside existing ones. Single-cell transcriptomics and lineage tracing with Cre-driver lines generated by genome editing identified cholangiocytes as the source of de novo hepatocytes. We further identify active mTORC1 signalling in the uninjured liver of growing animal to be a regulator of the enhanced plasticity of cholangiocytes. Our study suggests cholangiocyte-to-hepatocyte transdifferentiation as the primary mechanism of liver regeneration during periods of rapid growth.